Rachel Grashow, PhD, MS; Douglas P. Terry, PhD; Grant L. Iverson, PhD; et al.
open access
has audio
JAMA Neurol. 2024;81(11):1130-1139. doi:10.1001/jamaneurol.2024.3083
This cross-sectional study gathered data using surveys from former professional players of American-style football to gauge how many perceive that they have chronic traumatic encephalopathy and determine clinically relevant correlates, including suicidality.
-
Podcast:
Perceived CTE in Former Professional Football Players
Stewart J. Tepper, MD; David W. Dodick, MD; Michel Lanteri-Minet, MD, PhD; et al.
open access
JAMA Neurol. 2024;81(11):1140-1149. doi:10.1001/jamaneurol.2024.3043
This study assesses erenumab efficacy and safety in patients with nonopioid chronic migraine and medication overuse headaches.
Moniek Maarse, MD, PhD; David J. Seiffge, MD; David J. Werring, MD, PhD; et al.
JAMA Neurol. 2024;81(11):1150-1158. doi:10.1001/jamaneurol.2024.2882
This cohort study examines data from an international collaboration for patients with atrial fibrillation who have ischemic stroke despite taking oral anticoagulation therapy to compare percutaneous left atrial appendage occlusion with continuing oral anticoagulation therapy alone for stroke prevention.
Sahar F. Zafar, MD, MSc; Adithya Sivaraju, MD; Clio Rubinos, MD, MS; et al.
JAMA Neurol. 2024;81(11):1159-1169. doi:10.1001/jamaneurol.2024.3189
This cohort study examines factors and outcomes associated with antiseizure medication use in patients with confirmed or suspected acute symptomatic seizures.
Amber Salter, PhD; Samantha Lancia, MS; Kaarina Kowalec, PhD; et al.
open access
JAMA Neurol. 2024;81(11):1170-1177. doi:10.1001/jamaneurol.2024.2920
This cohort study uses a meta-analytic approach with data from phase 3 clinical trials of disease-modifying therapies to evaluate the association of comorbidities with disease activity in people with multiple sclerosis.
Jimmy Li, MD; Nathan A. Shlobin, MD; Roland D. Thijs, MD, PhD; et al.
JAMA Neurol. 2024;81(11):1178-1186. doi:10.1001/jamaneurol.2024.3210
This cohort study investigates the association between risk of cardiovascular events (CVEs) and use of enzyme-inducing antiseizure medication in older adults with epilepsy.
Nora Möhn, MD; Lea Grote-Levi, MD; Mike P. Wattjes, MD, PhD; et al.
open access
JAMA Neurol. 2024;81(11):1187-1198. doi:10.1001/jamaneurol.2024.3324
This case series investigates if directly isolated allogenic virus–specific T cells are associated with a therapeutic outcome in patients with progressive multifocal leukoencephalopathy (PML).
Sara Larivière, PhD; Frédéric L. W. V. J. Schaper, MD, PhD; Jessica Royer, PsyD; et al.
JAMA Neurol. 2024;81(11):1199-1209. doi:10.1001/jamaneurol.2024.2952
This case-control study evaluates the association between areas of atrophy in the hippocampus and distant neuroimaging alterations and neurostimulation.